HB 1512 grants Oklahoma's Insurance Commissioner authority to operate a state-based health insurance exchange under the Affordable Care Act, including applying for federal waivers. It creates a dedicated "State-based Exchange Revolving Fund" to support the exchange's operations and requires the Commissioner to promulgate necessary rules. The bill directly affects Oklahomans purchasing health insurance through the state marketplace by enabling a state-run exchange option. It becomes effective July 1, 2025, and was enacted without the Governor's signature on May 15, 2025.
This Oklahoma bill establishes a maximum staffing ratio requiring retail pharmacies to maintain no more than five pharmacy technicians for every one licensed pharmacist. It also updates regulations for pharmacy technicians by mandating permits, setting a renewal fee of up to $75 annually, and outlining procedures for late renewals and permit reinstatement. The law applies to all licensed retail pharmacies in Oklahoma and takes effect on November 1, 2025.
SB 251 expands eligibility for Oklahoma county mental health and substance abuse funding to include employment, education, and housing programs alongside existing treatment services. It requires the state to allocate at least 0.5% of total funds to each county government or multi-county partnership applying for grants. The bill also mandates annual reports to legislative leaders detailing funding distribution and services provided. These changes aim to broaden community-based support options while ensuring minimum funding for all participating counties.
HB 1658 regulates laser hair removal practitioners in Oklahoma by requiring all providers to use only FDA-approved devices and hold specific licenses or certifications. It mandates a 40-hour training program for practitioners (completed internally or via third parties under physician oversight), requires facilities to be overseen by a physician (with exemptions for Advanced Practice Registered Nurses), and establishes protocols for patient evaluations, informed consent, and complication management. The law also specifies that physicians must be available for real-time communication during procedures but need not be physically present. This bill directly affects laser hair removal practitioners, clinics, and supervising physicians, becoming effective immediately upon passage as an emergency measure.
SB 927 amends Oklahoma's Medicaid Drug Utilization Review Board procedures by prohibiting the pharmaceutical industry representative from voting on drug-related matters. It updates the appointment process to stagger initial terms for one physician, one pharmacist, and the lay representative to ensure board continuity. The bill affects the Oklahoma Health Care Authority and the board members, with changes taking effect November 1, 2025. The board's composition (10 members: 4 physicians, 4 pharmacists, 1 lay representative, 1 pharmaceutical industry rep) and appointment lists remain unchanged.
SB 723 updates Oklahoma law to clarify which positions at the Oklahoma Department of Veterans Affairs are exempt from standard civil service rules. It adds 11 specific healthcare and administrative roles - including physician assistants, pharmacists, occupational therapists, and Veterans Center administrators - to the list of exempt positions. The bill removes outdated references to previous exemption methods and confirms existing exempt positions remain unaffected. This change takes effect November 1, 2025.
SB 786 prohibits consuming marijuana or possessing open marijuana containers in the passenger area of any moving vehicle on public roads, and bans inhaling secondhand marijuana smoke while driving. It increases the trauma-care fee for violations from $100 to $250, requiring payment into Oklahoma's Trauma Care Assistance Fund. The law applies to all drivers on public highways, streets, or alleys, with exemptions only for buses and limousines (where drivers still cannot consume alcohol or marijuana). It became law without the governor's signature on May 14, 2025, and takes effect November 1, 2025.
SB 391 extends the Opioid Overdose Fatality Review Board's existence until July 1, 2026 (correcting the bill title's "dissolving" error), requiring it to review opioid overdose cases involving adults. The Board gathers confidential records from medical examiners, hospitals, law enforcement, and other agencies to identify systemic issues in medical or law enforcement responses, then makes recommendations for improvement. All case discussions and recommendations remain confidential and privileged, not admissible in court, while the Board must publish an annual public report by February 1 detailing its findings and system coordination. This directly affects state agencies (like mental health services, law enforcement, and medical examiners) and ensures public transparency through annual reports.
HB 2047, the Emerson Kate Cole Act, updates Oklahoma school medication policies to improve safety for students with allergies and asthma. It requires school districts to adopt policies allowing students to self-administer prescribed asthma inhalers, epinephrine for allergic reactions, and cystic fibrosis medications, with written parental permission and physician documentation. Key provisions include mandating annual staff training on recognizing allergic reactions and administering epinephrine, requiring schools to notify parents after medication use, and specifying protocols for stocking and using epinephrine injectors (including 911 contact procedures). The bill also creates model policies for districts to follow and clarifies that schools and staff incur no liability for medication administration under these guidelines. This law, effective May 14, 2025, directly affects public school districts, students with chronic conditions, and their families.
This bill amends Oklahoma law to add a new member representing federally recognized American Indian tribes to the state Medicaid Advisory Committee, expanding the committee's composition to include sixteen members instead of fifteen. The change ensures tribal representation on the advisory body that reviews Medicaid policy, program administration, and health care service delivery for public assistance recipients. The bill also updates appointment terms to a maximum of four consecutive years and clarifies that committee members receive travel reimbursement but no compensation for their service. Effective November 1, 2025, the committee will continue its existing duties of providing recommendations to the Oklahoma Health Care Authority while incorporating the new tribal member's perspective.
